Impact of Clonal Hematopoiesis on Solid Tumor Progression Following Radiation Therapy
We found no difference in irradiated tumor progression between patients with and without CH. Further studies are warranted to examine the potential clinical implications of CH on treatment responsiveness of solid tumors.
Authors
- Elizabeth Comen (ORCID: https://orcid.org/0000-0002-9179-0399)
- Jacqueline J. Tao (ORCID: https://orcid.org/0000-0003-1806-1269)
- Ross L. Levine (ORCID: https://orcid.org/0000-0002-7884-1905)
- Nadeem Riaz (ORCID: https://orcid.org/0000-0001-9873-5862)
- Pedram Razavi (ORCID: https://orcid.org/0000-0003-4236-0576)
- Anton Safonov (ORCID: https://orcid.org/0000-0002-4100-8071)
- Lior Z. Braunstein (ORCID: https://orcid.org/0000-0002-5127-0217)
- Larry Norton (ORCID: https://orcid.org/0000-0003-3701-9250)
- Atif J. Khan (ORCID: https://orcid.org/0000-0001-8640-8530)
- Simon N. Powell (ORCID: https://orcid.org/0000-0002-8183-4765)
- Jeremy Setton (ORCID: https://orcid.org/0000-0002-0263-2306)
- Jorge S. Reis‐Filho (ORCID: https://orcid.org/0000-0003-2969-3173)
- Pablo Sánchez Vela (ORCID: https://orcid.org/0000-0002-9286-8290)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Columbia University Irving Medical Center (US)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1200/po-24-00548
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.94